Ten Simple Rules for Protecting Research Integrity

PLoS Computational Biology

Volumn 11, Issue 10, 2015, Pages

  Shaw, David M ^a   Erren, Thomas C ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RESEARCH INTEGRITIES; SIMPLE++;

ACCOUNTING; ACCURACY; CONFLICT OF INTEREST; DECISION MAKING; EDITORIAL; EVIDENCE BASED PRACTICE; MALPRACTICE; MEDICAL RESEARCH; PRACTICE GUIDELINE; PUBLISHING; RESEARCH ETHICS; RESEARCH INTEGRITY; SCIENTIFIC LITERATURE; ALGORITHM; INTERPERSONAL COMMUNICATION; PROTOCOL COMPLIANCE; QUALITY CONTROL; RESEARCH; SCIENTIFIC MISCONDUCT; STANDARDS;

ALGORITHMS; DISCLOSURE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; QUALITY CONTROL; RESEARCH; SCIENTIFIC MISCONDUCT;

EID: 84946044509     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004388     Document Type: Editorial

References (38)

1. Godecharle S, Nemery B, Dierickx K, (2013) Guidance on research integrity: no union in Europe. Lancet 381:1097–1098. doi: 10.1016/S0140-6736(13)60759-X 23540852
2. Wager E, (2013) The UK should lead the way on research integrity. BMJ 346:f2348. doi: 10.1136/bmj.f2348 23610377
3. Lancet (2002) The next step: ensuring integrity of scientific research. Lancet: 360:499. 12241647
4. Lancet (2012) Promoting research integrity: a new global effort. Lancet 380: 1445. doi: 10.1016/S0140-6736(12)61822-4 23101698
5. Titus SL, Wells JA, Rhoades LJ, (2008) Repairing research integrity. Nature 453:980–982. doi: 10.1038/453980a 18563131
6. Martinson BC, Anderson MS, de Vries R, (2005) Scientists behaving badly. Nature 435: 737–738. 15944677
7. Foundation/ALLEA ES. European code of conduct for research integrity. http://www.esf.org/fileadmin/Public_documents/Publications/Code_Conduct_ResearchIntegrity.pdf. Accessed: March 4, 2015.
8. Council ER. (2012) European scientific misconduct strategy. http://erc.europa.eu/sites/default/files/document/file/ERC_Scientific_misconduct_strategy.pdf. Accessed: March 4, 2015.
9. Associated Press in Tokyo (2014) Stap cells: research paper on stem cell breakthrough was partly falsified. The Guardian. http://www.theguardian.com/science/2014/apr/01/stap-cells-research-paper-on-stem-cell-breakthrough-was-partly-falsified. Accessed: March 4, 2015.
10. Jefferson T, Doshi P, (2014) Multisystem failure: the story of anti-influenza drugs. BMJ 348: g2263. doi: 10.1136/bmj.g2263 24721793
11. van Raaij MJ, (2010) Guest authors: for contributors only. Nature 468: 765. doi: 10.1038/468765d 21150982
12. Rennie D, Yank V, Emanuel L, (1997) When authorship fails. A proposal to make contributors accountable. JAMA 278: 579–585. 9268280
13. ICMJE (2014) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. Updated December 2014. http://www.icmje.org/recommendations. Accessed: March 4, 2015.
14. Shaw D, (2011) The ICMJE's definition of authorship is illogical and unethical. BMJ 343: d7192. doi: 10.1136/bmj.d7192 22065677
15. Shaw D, (2014) The prisoners' dilemmas: Authorship guidelines and impact factors: between a rock and a hard place. EMBO reports 15: 635–637. doi: 10.1002/embr.201338348 24781693
16. Smith R, (1997) Authorship is dying: long live contributorship. BMJ 315: 696. 9314747
17. Kaplan K, (2010) Academia: The changing face of tenure. Nature 468: 123–125. 21157983
18. Glass RM, (2010) Guest authors: no place in any journal. Nature 468: 765. doi: 10.1038/468765e 21150979
19. BMJ. Authorship and contributorship. http://www.bmj.com/about-bmj/resources-authors/article-submission/authorship-contributorship. Accessed: March 4, 2015.
20. Yank V, Rennie D, (1997) Disclosure of researcher contributions: a study of original research articles in The Lancet. Annals of internal medicine 130: 661–670.
21. Rochon et al. Financial Conflicts of Interest Checklist 2010 for clinical research studies. Open Medicine 2010;4(1):E69–E91. 21686297
22. Goldacre B (2013) Bad Pharma. UK: Fourth Estate.
23. Horrobin DF, (1999) Beyond conflict of interest. Non-financial conflicts of interest are more serious than financial conflicts. BMJ 318: 466. 10084844
24. Shaw DM, (2014) A piece of my mind. Beyond conflicts of interest: disclosing medical biases. JAMA 312: 697–698. doi: 10.1001/jama.2014.8035 25138329
25. The Lancet. Statements, permissions, and signatures. http://www.thelancet.com/lancet-information-for-authors/statements-permissions-signatures. Accessed: March 4, 2015.
26. Erren TC, (2012) Competing interests: Judged in perpetuity. Nature 488: 590. doi: 10.1038/488590c 22932368
27. Chalmers I, Glasziou P, Godlee F, (2013) All trials must be registered and the results published. BMJ 346: f105. doi: 10.1136/bmj.f105 23303893
28. Health Research Authority. Transparency, registration and publication. http://www.hra.nhs.uk/resources/during-and-after-your-study/transparency-registration-and-publication/. Accessed: March 4, 2015.
29. All Trials. (2013) Agreement reached in Europe on Clinical Trials Regulation. http://www.alltrials.net/2013/agreement-reached-europe-clinical-trials-regulation. Accessed: March 4, 2015.
30. Bloom T (2013) Data Access for the Open Access Literature: PLOS’s Data Policy. http://www.plos.org/data-access-for-the-open-access-literature-ploss-data-policy/. Accessed: March 4, 2015.
31. Avon Longitudinal Study of Parents and Children. Access policy. v. 6.1 (June 2015) http://www.bristol.ac.uk/media-library/sites/alspac/documents/Access%20Policy.pdf (Accessed 13/9/15)
32. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gulmezoglu AM, et al. (2014) How to increase value and reduce waste when research priorities are set. Lancet 383: 156–165. doi: 10.1016/S0140-6736(13)62229-1 24411644
33. Fanelli D, (2013) Why growing retractions are (mostly) a good sign. PLoS medicine 10: e1001563. doi: 10.1371/journal.pmed.1001563 24311988
34. Fanelli D, (2014) Publishing: Rise in retractions is a signal of integrity. Nature 509: 33. doi: 10.1038/509033a 24784207
35. Michalek AM, Hutson AD, Wicher CP, Trump DL, (2010) The costs and underappreciated consequences of research misconduct: a case study. PLoS medicine 7: e1000318. doi: 10.1371/journal.pmed.1000318 20808955
36. Ayers I, Braithwaite J, Responsive Regulation. Transcending the deregulation debate. New York: Oxford University Press, 1992.
37. Boyd EA1, Cho MK, Bero LA, Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med. 2003 Aug;78(8):769–74. 12915362
38. Resnik DB, Master Z, (2013) Policies and initiatives aimed at addressing research misconduct in high-income countries. PLoS Medicine 10:e1001406. doi: 10.1371/journal.pmed.1001406 23555198